Ho Man Chan

5.0k total citations · 2 hit papers
24 papers, 2.7k citations indexed

About

Ho Man Chan is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Ho Man Chan has authored 24 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Ho Man Chan's work include Protein Degradation and Inhibitors (7 papers), Genomics and Chromatin Dynamics (6 papers) and Epigenetics and DNA Methylation (5 papers). Ho Man Chan is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Genomics and Chromatin Dynamics (6 papers) and Epigenetics and DNA Methylation (5 papers). Ho Man Chan collaborates with scholars based in United States, United Kingdom and South Korea. Ho Man Chan's co-authors include Nicholas B. La Thangue, David M. Livingston, Linda Smith, Marija Krstic–Demonacos, Luis M. Soares, Cigall Kadoch, Steven R. Grossman, Yoshihiro Nakatani, Constantinos Demonacos and Andrew L. Kung and has published in prestigious journals such as Science, Genes & Development and Blood.

In The Last Decade

Ho Man Chan

24 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

p300/CBP proteins: HATs for transcriptional bridges and scaffolds

2001 891 citations Ho Man Chan, Nicholas B. La Thangue Journal of Cell Science profile →
Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies

2020 227 citations Richard C. Centore, Gabriel J. Sandoval et al. Trends in Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ho Man Chan United States	14	2.3k	737	333	300	289	24	2.7k
Yegor Vassetzky France	35	2.7k 1.2×	456 0.6×	404 1.2×	232 0.8×	310 1.1×	160	3.4k
Mark A. Subler United States	32	2.0k 0.9×	1.5k 2.0×	268 0.8×	256 0.9×	412 1.4×	65	3.0k
Takaaki Sato Japan	18	1.6k 0.7×	802 1.1×	388 1.2×	350 1.2×	499 1.7×	34	2.6k
Yunmei Ma United States	18	3.0k 1.3×	857 1.2×	365 1.1×	410 1.4×	526 1.8×	22	3.4k
Leo Kretzner United States	21	3.1k 1.4×	782 1.1×	325 1.0×	285 0.9×	297 1.0×	28	3.6k
François Dautry France	30	2.2k 1.0×	420 0.6×	269 0.8×	404 1.3×	263 0.9×	61	3.1k
N. C. Tolga Emre United States	10	3.1k 1.4×	347 0.5×	273 0.8×	374 1.2×	224 0.8×	13	3.6k
Jurgen A. Marteijn Netherlands	29	4.1k 1.8×	999 1.4×	484 1.5×	209 0.7×	416 1.4×	62	4.5k
Tokameh Mahmoudi Netherlands	27	2.4k 1.1×	339 0.5×	252 0.8×	383 1.3×	175 0.6×	56	3.2k
Eric Wang United States	22	3.2k 1.4×	435 0.6×	269 0.8×	240 0.8×	320 1.1×	36	3.8k

Countries citing papers authored by Ho Man Chan

Since Specialization

Citations

This map shows the geographic impact of Ho Man Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho Man Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho Man Chan more than expected).

Fields of papers citing papers by Ho Man Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho Man Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho Man Chan. The network helps show where Ho Man Chan may publish in the future.

Co-authorship network of co-authors of Ho Man Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Ho Man Chan. A scholar is included among the top collaborators of Ho Man Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho Man Chan. Ho Man Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Xufen, Bo Pan, Ho Man Chan, et al.. (2025). Pharmacologic degradation of WDR5 suppresses oncogenic activities of SS18::SSX and provides a therapeutic of synovial sarcoma. Science Advances. 11(17). eads7876–eads7876. 2 indexed citations

Oien, Derek B., Samanta Sharma, Maureen M. Hattersley, et al.. (2023). BET inhibition targets ABC-DLBCL constitutive B-cell receptor signaling through PAX5. Blood Advances. 7(17). 5108–5121. 7 indexed citations

Lynch, James T., Shaun Moore, Iván del Barco Barrantes, et al.. (2023). Abstract 6272: AZ-PRMT5i-1: A potent MTAP-selective PRMT5 inhibitor with pharmacodynamic and monotherapy anti-tumor activity in MTAP-deleted tumours. Cancer Research. 83(7_Supplement). 6272–6272. 2 indexed citations

Urosevic, Jelena, James T. Lynch, Nevin Yusufova, et al.. (2023). Epigenetic Silencing of MTAP in Hodgkin's Lymphoma Renders It Sensitive to a 2 nd Generation PRMT5 Inhibitor. Blood. 142(Supplement 1). 4185–4185. 2 indexed citations

Jiang, Junjie, Jiao Yuan, Zhongyi Hu, et al.. (2022). Systematic illumination of druggable genes in cancer genomes. Cell Reports. 38(8). 110400–110400. 24 indexed citations

Hu, Zhongyi, Jiao Yuan, Meixiao Long, et al.. (2021). The Cancer Surfaceome Atlas integrates genomic, functional and drug response data to identify actionable targets. Nature Cancer. 2(12). 1406–1422. 61 indexed citations

Jiang, Junjie, Jiao Yuan, Zhongyi Hu, et al.. (2021). Systematic Pan-Cancer Characterization of Nuclear Receptors Identifies Potential Cancer Biomarkers and Therapeutic Targets. Cancer Research. 82(1). 46–59. 6 indexed citations

Centore, Richard C., Gabriel J. Sandoval, Luis M. Soares, Cigall Kadoch, & Ho Man Chan. (2020). Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies. Trends in Genetics. 36(12). 936–950. 227 indexed citations breakdown →

Argent, Stephen P., Ho Man Chan, Christopher G. P. Taylor, et al.. (2020). A family of diastereomeric dodecanuclear coordination cages based on inversion of chirality of individual triangular cyclic helicate faces. Chemical Science. 11(37). 10167–10174. 15 indexed citations

10.

Michel, Brittany C., Seth H. Cassel, Nazar Mashtalir, et al.. (2018). A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation. Nature Cell Biology. 20(12). 1410–1420. 248 indexed citations

11.

LaRochelle, Jonathan R., Michelle Fodor, Xiang Xu, et al.. (2016). Structural and Functional Consequences of Three Cancer-Associated Mutations of the Oncogenic Phosphatase SHP2. Biochemistry. 55(15). 2269–2277. 46 indexed citations

12.

Chan, Ho Man, et al.. (2016). Piece by piece: understanding graffiti-writing in Hong Kong. 12(1). 44–62. 1 indexed citations

13.

Li, Shu, Hong Fan, Ling Li, et al.. (2013). A liquid chromatography/mass spectrometry-based generic detection method for biochemical assay and hit discovery of histone methyltransferases. Analytical Biochemistry. 443(2). 214–221. 7 indexed citations

14.

Gévry, Nicolas, Ho Man Chan, Liette Laflamme, David M. Livingston, & Luc Gaudreau. (2007). p21 transcription is regulated by differential localization of histone H2A.Z. Genes & Development. 21(15). 1869–1881. 217 indexed citations

15.

Chan, Ho Man, Masako Narita, Scott W. Lowe, & David M. Livingston. (2005). The p400 E1A-associated protein is a novel component of the p53 → p21 senescence pathway. Genes & Development. 19(2). 196–201. 113 indexed citations

16.

Chan, Ho Man, Linda Smith, & Nicholas B. La Thangue. (2001). Role of LXCXE motif-dependent interactions in the activity of the retinoblastoma protein. Oncogene. 20(43). 6152–6163. 64 indexed citations

17.

Chan, Ho Man, Marija Krstic–Demonacos, Linda Smith, Constantinos Demonacos, & Nicholas B. La Thangue. (2001). Acetylation control of the retinoblastoma tumour-suppressor protein. Nature Cell Biology. 3(7). 667–674. 232 indexed citations

18.

Chan, Ho Man & Nicholas B. La Thangue. (2001). p300/CBP proteins: HATs for transcriptional bridges and scaffolds. Journal of Cell Science. 114(13). 2363–2373. 891 indexed citations breakdown →

19.

Shikama, Noriko, Ho Man Chan, Marija Krstic–Demonacos, et al.. (2000). Functional Interaction between Nucleosome Assembly Proteins and p300/CREB-Binding Protein Family Coactivators. Molecular and Cellular Biology. 20(23). 8933–8943. 134 indexed citations

20.

Ivens, Alasdair, et al.. (1998). A Physical Map of the Leishmania majorFriedlin Genome. Genome Research. 8(2). 135–145. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact